Compare ARK Genomic Revolution ETF (ARKG) vs Iron Mountain Inc (IRM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Iron Mountain Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Iron Mountain Inc trades at $121.55 (market cap $36.15B). The key difference: Iron Mountain Inc pays a 2.84% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | IRM | |
|---|---|---|
Sector | Sector/Thematic | Real Estate |
52-Week High | $43.57 | $133.06 |
52-Week Low | $23.09 | $78.86 |
Market Cap | — | $36.15B |
Enterprise Value | — | $55.29B |
Dividend Yield | — | 2.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Iron Mountain (IRM) trades at $121.50, up 1.69% today, with strong recent earnings beats and a bullish analyst consensus of 65% buy ratings. The stock shows a bearish technical signal but is supported by positive momentum in data center demand and a recent $1.5 billion debt offering. Revenue growth is steady, though net margins are thin at 3.76%, and the company carries high debt levels with a debt-to-asset ratio of 74.39% as of 2024.
Outlook is mixed: robust data center growth and dividend yield offer upside, but high valuation (P/E 132.08) and leverage pose risks. The consensus price target of $138.67 suggests 14% potential upside, yet technical resistance near $122 may limit near-term gains. Investors should weigh strong institutional support against elevated financial risk.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →
